
1. ebiomedicine. 2019 jul;45:290-302. doi: 10.1016/j.ebiom.2019.06.043. epub 2019
jul 2.

integrated omics platforms identify lair1 genetic variants novel predictors of
cross-sectional longitudinal susceptibility severe malaria all-cause
mortality kenyan children.

achieng ao(1), hengartner nw(2), raballah e(3), cheng q(4), anyona sb(5), lauve
n(4), guyah b(6), foo-hurwitz i(4), ong'echa jm(7), mcmahon bh(2), ouma c(1),
lambert cg(4), perkins dj(8).

author information: 
(1)university new mexico-kenya global health programs, kisumu siaya,
kenya; department biomedical sciences technology, school public health 
and community development, maseno university, maseno, kenya.
(2)theoretical biology biophysics group, theoretical division, los alamos
national laboratory, los alamos, nm, usa.
(3)university new mexico-kenya global health programs, kisumu siaya,
kenya; department medical laboratory sciences, school public health
biomedical sciences technology, masinde muliro university science and
technology, kakamega, kenya.
(4)university new mexico, center global health, department internal
medicine, nm, usa.
(5)university new mexico-kenya global health programs, kisumu siaya,
kenya; department medical biochemistry, school medicine, maseno university,
maseno, kenya.
(6)department biomedical sciences technology, school public health 
community development, maseno university, maseno, kenya.
(7)kenya medical research institute, centre global health research, kisumu,
kenya.
(8)university new mexico-kenya global health programs, kisumu siaya,
kenya; university new mexico, center global health, department internal
medicine, nm, usa. electronic address: dperkins@salud.unm.edu.

background: severe malarial anaemia (sma) leading cause childhood
mortality holoendemic plasmodium falciparum regions.
methods: gain improved understanding sma pathogenesis, whole genome 
transcriptome profiling performed kenyan children (n=144, 3-36months) with
discrete non-sma sma phenotypes. leukocyte associated immunoglobulin like
receptor 1 (lair1) emerged predictor susceptibility sma (p<1×10-2, or:
0.44-1.37), suppressed severe disease (-1.69-fold, p=0.004). extend
these findings, relationship lair1 polymorphisms [rs6509867
(16231c>a); rs2287827 (18835g>a)] clinical outcomes investigated in
individuals (n=1512, <5years) enrolment 36-month longitudinal
follow-up.
findings: inheritance 16,231 recessive genotype (aa) increased
susceptibility sma enrolment (or=1.903, 95%ci: 1.252-2.891, p=0.003), and
longitudinally (rr=1.527, 95%ci: 1.119-2.083, p=0.008). carriage 18,835 ga
genotype protected sma cross-sectionally (or=0.672, 95%ci: 0.480-0.9439, 
p=0.020). haplotype carriage (c16231a/g18835a) also altered cross-sectional
susceptibility sma: cg (or=0.717, 95%ci: 0.527-0.9675, p=0.034), ca (or=0.745,
95%ci: 0.536-1.036, p=0.080), ag (or=1.641, 95%ci: 1.160-2.321, p=0.005).
longitudinally, ca carriage protective sma (rr=0.715, 95%ci:
0.554-0.923, p=0.010), ag carriage additive effect enhanced sma
risk (rr=1.283, 95%ci: 1.057-1.557, p=0.011). variants protected sma
had elevated lair1 transcripts, enhanced risk lower
expression (p<0.05). inheritance 18,835 ga reduced all-cause mortality by
44.8% (hr=0.552, 95%ci: 0.329-0.925, p=0.024), ag haplotype carriage
increased susceptibility 68% (hr=1.680, 95%ci: 1.020-2.770, p=0.040).
interpretation: findings suggest lair1 important modulating
susceptibility sma all-cause childhood mortality.

copyright © 2019. published elsevier b.v.

doi: 10.1016/j.ebiom.2019.06.043 
pmcid: pmc6642287
pmid: 31278068  [indexed medline]

